Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective
Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective
复制标题
DOI：
10.1097/mpg.0000000000002139
复制
发表时间：
2019-01-01
影响因子：
2.9
通讯作者：
Satsangi, Sandeep
中科院分区：
文献类型：
--
作者：
Dhiman, Radha K.;Grover, Gagandeep S.;Satsangi, Sandeep
目标：我们评估了 Mukh-Mantri 旁遮普丙型肝炎救济基金中分散的公共卫生服务和直接作用抗病毒药物 (DAA) 在治疗儿童慢性丙型肝炎 (CHC) 方面的有效性和安全性，该基金是印度旁遮普邦预防和控制 CHC 的一项公共卫生举措。方法：连续患有 CHC 的儿童 [年龄 >= 12 至
Objectives: We assessed the efficacy of decentralized public health services and safety of direct-acting antiviral agents (DAAs) in the treatment of pediatric chronic hepatitis C (CHC) in the Mukh-Mantri Punjab Hepatitis C Relief Fund, a public-health initiative for prevention and control of CHC in Punjab, India. Methods: Consecutive children with CHC [age >= 12 to